MedVi vs Maximus: Compare compounded semaglutide options
MedVi vs Maximus is a price and process comparison for compounded semaglutide telehealth. Quick verdict: Maximus is the lower flat-rate option at $132.99/month, while MedVi emphasizes a promotional first month at $179 with 24/7 certified medical support and a no-clinic process.
How they deliver care and medication
Both MedVi and Maximus operate as telemedicine platforms with no in-person clinic visits required and prescriptions approved by licensed clinicians. MedVi highlights a simple online intake and 24/7 support from certified medical professionals. Maximus emphasizes convenient telemedicine access and prescriptions filled through trusted U.S. pharmacies.
Price structure and transparency
The most distinctive difference is pricing. Maximus offers a low flat rate at $132.99/month according to its landing information and positions that as a predictable direct-pay cost. MedVi advertises a winter promotional price starting at $179 for the first month including fast, free shipping, but notes the ongoing standalone month price increases to $299 and a three-month plan is available at $649 (about $216/month).
Cost clarity and ongoing commitments
MedVi explicitly warns the first-month rate is promotional and that ongoing price is substantially higher than the promo. Maximus presents $132.99/month as a consistent low flat rate with no membership fees according to its materials.
Medication type and sourcing
Both providers offer compounded semaglutide rather than branded finished products. MedVi states it provides clinically dosed compounded semaglutide and works with USA certified pharmacies. Maximus states medications are compounded in U.S. pharmacies and prescriptions are approved by licensed doctors. Both include the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality.
Support and program features
MedVi highlights 24/7 certified medical support, a personalized plan that may include physician review, 1:1 guidance, and metabolic reporting as part of its program. Maximus emphasizes approvals by licensed doctors, free expedited shipping in some offers, and eligibility in 49 or 50 states depending on the captured copy, with a note that some availability exclusions apply in certain states.
| Criteria | MedVi | Maximus |
|---|---|---|
| Starting price | Winter promo starting at $179 for first month including fast, free shipping | Low flat rate at $132.99/month |
| Ongoing cost | Standalone month $299; three-month plan $649 (about $216/month) | $132.99/month direct-pay flat rate |
| Medication type | Clinically dosed compounded semaglutide | Compounded semaglutide filled in U.S. pharmacies |
| Clinical support | 24/7 certified medical support; online clinician review | Prescriptions approved by licensed doctors; telemedicine access |
| Regulatory note | Compounded medications not FDA-approved; not reviewed by FDA | Compounded medications not FDA-approved; not reviewed by FDA |
Limitations and who each is best for
MedVi is well-suited for patients who want the simplest path to compounded semaglutide therapy with 24/7 support and a promotional first month. Maximus is best for patients prioritizing the lowest predictable monthly cost and U.S. pharmacy fulfillment.
Safety, eligibility, and program notes
Both platforms note prescriptions are subject to clinician review and medical eligibility. MedVi states an OpenLoop Health clinician will meet with an individual after checkout to determine if they qualify for a prescription and that providers retain discretion to prescribe compounded GLP-1s. Maximus states prescriptions are approved by licensed doctors and that if a user is not approved for treatment, medication costs will be fully refunded per its landing copy. Both emphasize that compounded medications are not FDA-approved and recommend discussing risks and benefits with a provider.
Comparison summary and final guidance
MedVi vs Maximus breaks down to a tradeoff between an introductory promo plus 24/7 support and a lower flat monthly rate. MedVi offers a $179 first-month promotional price with robust support and an online-only pathway, but ongoing months cost more. Maximus offers a consistent $132.99/month rate, U.S. pharmacy fulfillment, and a direct-pay model with telemedicine approval.
Choose Maximus for lowest monthly rate
Choose MedVi if you want a promotional first month, 24/7 certified medical support, and a fully online intake with clinician review. Choose Maximus if your priority is a lower flat monthly price at $132.99/month with prescriptions filled through trusted U.S. pharmacies. Both use compounded semaglutide and note that compounded medications are not FDA-approved and are prescribed subject to clinician review.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →More comparisons
